Generation and validation of a D1 dopamine receptor Flpo knock-in mouse

被引:0
|
作者
Oppman, Alexis M. [1 ]
Paradee, William J. [3 ]
Narayanan, Nandakumar S. [1 ,2 ]
Kim, Young-cho [1 ,2 ]
机构
[1] Univ Iowa, Dept Biomed Engn, Iowa City, IA 52241 USA
[2] Iowa Neurosci Inst, Iowa City, IA 52242 USA
[3] Univ Iowa, Genome Editing Core Facil, Iowa City, IA 52246 USA
基金
美国国家卫生研究院;
关键词
D1 dopamine receptor; D1DR; Transgenic animal CRISPR-Cas9; Flpo recombinase; Intersectional genetics; EXPRESSING NEURONS; D-1; LOCALIZATION; CORTEX;
D O I
10.1016/j.jneumeth.2024.110345
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Background: Dopamine is a powerful neuromodulator of diverse brain functions, including movement, motivation, reward, and cognition. D1-type dopamine receptors (D1DRs) are the most prevalently expressed dopamine receptors in the brain. Neurons expressing D1DRs are heterogeneous and involve several subpopulations. Although these neurons can be studied with BAC-transgenic rodents, these models have some limitations especially when considering their integration with conditional or intersectional genetic tools. New Method: We developed a novel Drd1-P2A-Flpo (Drd1-Flpo) mouse line in which the Flpo gene was knocked in immediately after the Drd1 gene using CRISPR-Cas9. We validated the Drd1-Flpo line by confirming Flp expression and functionality specific to D1DR+ neurons with immunohistochemistry and in situ hybridization. Comparison with Existing Methods: The Drd1-Flpo line is a useful resource for studying subpopulations of D1DR+ neurons with intersectional genetic tools. Conclusions: We demonstrated brain-wide GFP expression driven by Drd1-Flpo, suggesting that this mouse line may be useful for comprehensive anatomical and functional studies in many brain regions. The Drd1-Flpo model will advance the study of dopaminergic signaling by providing a new tool for investigating the diverse roles of D1DR+ neurons and their subpopulations in brain disease.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Dopamine D1 receptor agonists as antiparkinson drugs
    Mailman, RB
    Nichols, DE
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1998, 19 (07) : 255 - 256
  • [42] ARE D1 DOPAMINE RECEPTOR AGONISTS POTENTIAL ANTIDEPRESSANTS
    SERRA, G
    COLLU, M
    DAQUILA, P
    PANI, L
    GESSA, GL
    PHARMACOLOGICAL RESEARCH COMMUNICATIONS, 1988, 20 (12): : 1121 - 1122
  • [43] Golfα mediates dopamine D1 receptor signaling
    Zhuang, XX
    Belluscio, L
    Hen, R
    JOURNAL OF NEUROSCIENCE, 2000, 20 (16): : art. no. - RC91
  • [44] HIGHLIGHTS OF D1 DOPAMINE RECEPTOR ANTAGONIST RESEARCH
    BARNETT, A
    MCQUADE, RD
    TEDFORD, C
    NEUROCHEMISTRY INTERNATIONAL, 1992, 20 : S119 - S122
  • [45] Cloning of the feline renal dopamine D1 receptor
    Edwards, HG
    Rogers, CB
    Wohl, JS
    Kemppainen, RJ
    Schwartz, DD
    FASEB JOURNAL, 2005, 19 (04): : A111 - A111
  • [46] Genetic variants of dopamine D2 receptor impact heterodimerization with dopamine D1 receptor
    Blasiak, Ewa
    Lukasiewicz, Sylwia
    Szafran-Pilch, Kinga
    Dziedzicka-Wasylewska, Marta
    PHARMACOLOGICAL REPORTS, 2017, 69 (02) : 235 - 241
  • [47] Genetic variants of dopamine D2 receptor impact heterodimerization with dopamine D1 receptor
    Ewa Błasiak
    Sylwia Łukasiewicz
    Kinga Szafran-Pilch
    Marta Dziedzicka-Wasylewska
    Pharmacological Reports, 2017, 69 : 235 - 241
  • [48] POSTMORTEM STABILITY OF DOPAMINE D1 RECEPTOR MESSENGER-RNA AND D1 RECEPTORS
    GILMORE, JH
    LAWLER, CP
    EATON, AM
    MAILMAN, RB
    MOLECULAR BRAIN RESEARCH, 1993, 18 (04): : 290 - 296
  • [49] The alleged dopamine D1 receptor agonist SKF 83959 is a dopamine D1 receptor antagonist in primate cells and interacts with other receptors
    Andringa, G
    Drukarch, B
    Leysen, JE
    Cools, AR
    Stoof, JC
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 364 (01) : 33 - 41
  • [50] Dopamine D1 Receptor Expression Is Bipolar Cell Type-Specific in the Mouse Retina
    Farshi, Pershang
    Fyk-Kolodziej, Bozena
    Krolewski, David M.
    Walker, Paul D.
    Ichinose, Tomomi
    JOURNAL OF COMPARATIVE NEUROLOGY, 2016, 524 (10) : 2059 - 2079